We hypothesize that the ingestion of quark will increase post-prandial muscle protein synthesis at rest in both young and older men. In addition, we hypothesize that exercise will augment the post-prandial muscle protein synthetic response to quark…
ID
Bron
Verkorte titel
Aandoening
Muscle mass growth; which can be related to sarcopenia
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Muscle protein synthesis
Achtergrond van het onderzoek
An important determinant to maintain and/or increase skeletal muscle mass in rest and after (resistance) exercise is dietary protein intake. Especially with aging ingestion of high-quality dietary proteins is a strategy to counteract sarcopenia. In this regard, milk protein has been studied frequently and is considered as a high-quality protein source. However, little is known about other milk-derived protein sources such as quark. Therefore, the aim of the present study is to assess the capacity of quark to stimulate post-prandial and post-exercise skeletal muscle protein synthesis when compared to basal, post-absorptive muscle protein synthesis in young and older males.
Doel van het onderzoek
We hypothesize that the ingestion of quark will increase post-prandial muscle protein synthesis at rest in both young and older men. In addition, we hypothesize that exercise will augment the post-prandial muscle protein synthetic response to quark ingestion in both young and older men.
Onderzoeksopzet
Muscle biopsies taken at -150, 0, and 240 min.
Onderzoeksproduct en/of interventie
Exercise and quark intake
Algemeen / deelnemers
Wetenschappers
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
• Healthy males
• Age between 18 and 35 y or 65 and 85 y inclusive
• BMI between 18.5 and 30 kg/m2
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
• Allergies to milk proteins
• Lactose intolerant
• Smoking
• Phenylketonuria
• Diabetes Mellitus (diagnosed, or fasting glucose >7.0 mmol/L, or HbA1c >6.5)
• Diagnosed GI tract disorders or diseases
• Arthritic conditions
• A history of neuromuscular problems
• Any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
• Use of certain anticoagulants (use of thrombocyte aggregation inhibitors such as acetylsalicylic acid and carbasalaatcalcium is permitted. Use of other thrombocyte aggregation inhibitors will be discussed with the responsible physician)
• Blood donation within 2 months of study initiation
• Hypertension (according to WHO criteria; >90/140 mmHg)
• Recent participation in amino acid tracer studies (less than 1 year ago)
• Physical activity (not training more than 3 times per week and no structured resistance training.)
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL8403 |
| Ander register | METC azM/UM : METC19-074 |